共 22 条
- [1] Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300[J]. ANNALS OF ONCOLOGY, 2018, 29 (10) : 2052 - 2060Bang, Y. -J.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaRuiz, E. Yanez论文数: 0 引用数: 0 h-index: 0机构: Univ La Frontera, Temuco, Chile Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaVan Cutsem, E.论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Digest Oncol, Univ Hosp Gasthuisberg Leuven, Leuven, Belgium Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaLee, K. -W.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Seongnam, South Korea Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaWyrwicz, L.论文数: 0 引用数: 0 h-index: 0机构: M Sklodowska Curie Mem Canc Ctr, Dept Gastrointestinal Canc, Warsaw, Poland Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaSchenker, M.论文数: 0 引用数: 0 h-index: 0机构: Cent Oncol Sf Nectarie, Craiova, Romania Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaAlsina, M.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain Vall dHebron Inst Oncol, Barcelona, Spain Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaRyu, M. -H.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaChung, H. -C.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ Hlth Syst, Yonsei Univ, Coll Med, Div Med Oncol,Yonsei Canc Ctr, Seoul, South Korea Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaEvesque, L.论文数: 0 引用数: 0 h-index: 0机构: Ctr Antoine Lacassagne, Dept Med Oncol, Nice, France Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaAl-Batran, S. -E.论文数: 0 引用数: 0 h-index: 0机构: Krankenhaus NW Frankfurt, Dept Clin Oncol & Hematol, Frankfurt, Germany Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaPark, S. H.论文数: 0 引用数: 0 h-index: 0机构: Samsung Med Ctr, Dept Med, Seoul, South Korea Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaLichinitser, M.论文数: 0 引用数: 0 h-index: 0机构: Russian Acad Med Sci, NN Blokhin Russian Oncol Sci Ctr, Dept Chemotherapy & Combined Therapy, Moscow, Russia Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaBoku, N.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Med Oncol Div, Dept Gastrointestinal, Tokyo, Japan Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaMoehler, M. H.论文数: 0 引用数: 0 h-index: 0机构: Johannes Gutenberg Univ Mainz, Dept Internal Med, Mainz, Germany Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaHong, J.论文数: 0 引用数: 0 h-index: 0机构: EMD Serono, Global Clin Dev Immunooncol, Billerica, MA USA Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaXiong, H.论文数: 0 引用数: 0 h-index: 0机构: EMD Serono, Global Clin Dev Immunooncol, Billerica, MA USA Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaHallwachs, R.论文数: 0 引用数: 0 h-index: 0机构: Merck KGaA, Global Res & Dev, Darmstadt, Germany Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaConti, I.论文数: 0 引用数: 0 h-index: 0机构: EMD Serono, Global Clin Dev Immunooncol, Billerica, MA USA Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South KoreaTaieb, J.论文数: 0 引用数: 0 h-index: 0机构: Paris Descartes Univ, Univ Sorbonne Paris Cite, Georges Pompidou European Hosp, Dept Gastroenterol & Digest Oncol, Paris, France Seoul Natl Univ, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
- [2] Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study[J]. GASTRIC CANCER, 2019, 22 (04) : 828 - 837Bang, Yung-Jue论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaKang, Yoon-Koo论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Div Oncol, Dept Internal Med, Seoul, South Korea Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaCatenacci, Daniel V.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago Med, Dept Med, Sect Hematol Oncol, Chicago, IL USA Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaMuro, Kei论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaFuchs, Charles S.论文数: 0 引用数: 0 h-index: 0机构: Yale Canc Ctr, Dept Med Oncol, New Haven, CT USA Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaGeva, Ravit论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, Tel Aviv, Israel Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaHara, Hiroki论文数: 0 引用数: 0 h-index: 0机构: Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaGolan, Talia论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Sackler Fac Med, Chaim Sheba Med Ctr, Dept Oncol,Oncol Inst, Tel Aviv, Israel Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaGarrido, Marcelo论文数: 0 引用数: 0 h-index: 0机构: Pontificia Univ Catolica Chile, Hematol & Med Oncol, Santiago, Chile Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaJalal, Shadia I.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ Sch Med, Dept Internal Med, Indianapolis, IN 46202 USA Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaBorg, Christophe论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Besancon, Dept Med Oncol, Besancon, France Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaDoi, Toshihiko论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaYoon, Harry H.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Dept Med Oncol, Rochester, MN USA Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaSavage, Mary J.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Med Oncol, Kenilworth, NJ USA Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaWang, Jiangdian论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Med Oncol, Kenilworth, NJ USA Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaDalal, Rita P.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Med Oncol, Kenilworth, NJ USA Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaShah, Sukrut论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Med Oncol, Kenilworth, NJ USA Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaWainberg, Zev A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South KoreaChung, Hyun Cheol论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea
- [3] Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial[J]. JAMA ONCOLOGY, 2018, 4 (05)Fuchs, Charles S.论文数: 0 引用数: 0 h-index: 0机构: Yale Canc Ctr, New Haven, CT USA Yale Canc Ctr, New Haven, CT USADoi, Toshihiko论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr East, Chiba, Japan Yale Canc Ctr, New Haven, CT USAJang, Raymond W.论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Canc Ctr, Toronto, ON, Canada Univ Toronto, Toronto, ON, Canada Yale Canc Ctr, New Haven, CT USAMuro, Kei论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan Yale Canc Ctr, New Haven, CT USASatoh, Taroh论文数: 0 引用数: 0 h-index: 0机构: Osaka Univ, Grad Sch Med, Suita, Osaka, Japan Yale Canc Ctr, New Haven, CT USAMachado, Manuela论文数: 0 引用数: 0 h-index: 0机构: Portuguese Inst Oncol, Porto, Portugal Yale Canc Ctr, New Haven, CT USASun, Weijing论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USA Univ Kansas, Kansas City, KS USA Yale Canc Ctr, New Haven, CT USAJalal, Shadia I.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ Sch Med, Indianapolis, IN 46202 USA Yale Canc Ctr, New Haven, CT USAShah, Manish A.论文数: 0 引用数: 0 h-index: 0机构: New York Presbyterian Hosp, Weill Cornell Med, New York, NY USA Yale Canc Ctr, New Haven, CT USAMetges, Jean-Phillipe论文数: 0 引用数: 0 h-index: 0机构: Brest Hop Morvan, CHRU, Brest, France Yale Canc Ctr, New Haven, CT USAGarrido, Marcelo论文数: 0 引用数: 0 h-index: 0机构: Pontificia Univ Catolica Chile, Santiago, Chile Yale Canc Ctr, New Haven, CT USAGolan, Talia论文数: 0 引用数: 0 h-index: 0机构: Chaim Sheba Med Ctr Tel Hashomer, Inst Oncol, Ramat Gan, Israel Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel Yale Canc Ctr, New Haven, CT USAMandala, Mario论文数: 0 引用数: 0 h-index: 0机构: ASST Papa Giovanni XXIII, Ctr Canc, Bergamo, Italy Yale Canc Ctr, New Haven, CT USAWainberg, Zev A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA Yale Canc Ctr, New Haven, CT USACatenacci, Daniel V.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago Med, Chicago, IL USA Yale Canc Ctr, New Haven, CT USAOhtsu, Atsushi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr East, Chiba, Japan Yale Canc Ctr, New Haven, CT USAShitara, Kohei论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr East, Chiba, Japan Yale Canc Ctr, New Haven, CT USAGeva, Ravit论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel Yale Canc Ctr, New Haven, CT USABleeker, Jonathan论文数: 0 引用数: 0 h-index: 0机构: Sanford Hlth, Sioux Falls, SD USA Yale Canc Ctr, New Haven, CT USAKo, Andrew H.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA Yale Canc Ctr, New Haven, CT USAKu, Geoffrey论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Yale Canc Ctr, New Haven, CT USAPhilip, Philip论文数: 0 引用数: 0 h-index: 0机构: Karmanos Canc Inst, Detroit, MI USA Yale Canc Ctr, New Haven, CT USAEnzinger, Peter C.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Harvard Med Sch, Boston, MA 02115 USA Yale Canc Ctr, New Haven, CT USABang, Yung-Jue论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Coll Med, Seoul, South Korea Yale Canc Ctr, New Haven, CT USALevitan, Diane论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Yale Canc Ctr, New Haven, CT USAWang, Jiangdian论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Yale Canc Ctr, New Haven, CT USARosales, Minori论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Yale Canc Ctr, New Haven, CT USADalal, Rita P.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Yale Canc Ctr, New Haven, CT USAYoon, Harry H.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Yale Canc Ctr, New Haven, CT USA
- [4] Approaches to treat immune hot, altered and cold tumours with combination immunotherapies[J]. NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (03) : 197 - 218Galon, Jerome论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Diderot, Univ Paris Descartes, Sorbonne Univ,Ctr Rech Cordeliers, INSERM,Lab Integrat Canc Immunol,Sorbonne Paris C, Paris, France Univ Paris Diderot, Univ Paris Descartes, Sorbonne Univ,Ctr Rech Cordeliers, INSERM,Lab Integrat Canc Immunol,Sorbonne Paris C, Paris, France论文数: 引用数: h-index:机构:
- [5] Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (14) : 1328 - 1339Herbst, Roy S.论文数: 0 引用数: 0 h-index: 0机构: Yale Sch Med, New Haven, CT USA Yale Sch Med, New Haven, CT USAGiaccone, Giuseppe论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med Ctr, New York, NY USA Yale Sch Med, New Haven, CT USAde Marinis, Filippo论文数: 0 引用数: 0 h-index: 0机构: IRCCS, European Inst Oncol, Milan, Italy Yale Sch Med, New Haven, CT USAReinmuth, Niels论文数: 0 引用数: 0 h-index: 0机构: Asklepios Lung Clin, Munich, Germany Yale Sch Med, New Haven, CT USAVergnenegre, Alain论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Limoges, Limoges, France Yale Sch Med, New Haven, CT USABarrios, Carlos H.论文数: 0 引用数: 0 h-index: 0机构: Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Ctr Pesquisa Clin, Porto Alegre, RS, Brazil Yale Sch Med, New Haven, CT USAMorise, Masahiro论文数: 0 引用数: 0 h-index: 0机构: Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan Yale Sch Med, New Haven, CT USAFelip, Enriqueta论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Barcelona, Spain Yale Sch Med, New Haven, CT USAAndric, Zoran论文数: 0 引用数: 0 h-index: 0机构: Clin Hosp Ctr Bezanijska Kosa, Belgrade, Serbia Yale Sch Med, New Haven, CT USAGeater, Sarayut论文数: 0 引用数: 0 h-index: 0机构: Prince Songkla Univ Hat Yai, Songkhla, Thailand Yale Sch Med, New Haven, CT USAOzguroglu, Mustafa论文数: 0 引用数: 0 h-index: 0机构: Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Istanbul, Turkey Yale Sch Med, New Haven, CT USAZou, Wei论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Yale Sch Med, New Haven, CT USASandler, Alan论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Yale Sch Med, New Haven, CT USAEnquist, Ida论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Yale Sch Med, New Haven, CT USAKomatsubara, Kimberly论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Yale Sch Med, New Haven, CT USADeng, Yu论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Yale Sch Med, New Haven, CT USAKuriki, Hiroshi论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Yale Sch Med, New Haven, CT USAWen, Xiaohui论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Yale Sch Med, New Haven, CT USAMcCleland, Mark论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Yale Sch Med, New Haven, CT USAMocci, Simonetta论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Yale Sch Med, New Haven, CT USA论文数: 引用数: h-index:机构:Spigel, David R.论文数: 0 引用数: 0 h-index: 0机构: Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA Yale Sch Med, New Haven, CT USA
- [6] Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China[J]. CANCER, 2019, 125 (05) : 742 - 749Huang, Jing论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaMo, Hongnan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaZhang, Weilong论文数: 0 引用数: 0 h-index: 0机构: Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, State Key Lab Mol Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaChen, Xuelian论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaQu, Dong论文数: 0 引用数: 0 h-index: 0机构: Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Diagnost Radiol, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaWang, Xi论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaWu, Dawei论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaWang, Xingyuan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaLan, Bo论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaYang, Beibei论文数: 0 引用数: 0 h-index: 0机构: Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, State Key Lab Mol Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaWang, Pei论文数: 0 引用数: 0 h-index: 0机构: Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, State Key Lab Mol Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaZhang, Bo论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaYang, Qing论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Hengrui Med Co Ltd, Shanghai, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaJiao, Yuchen论文数: 0 引用数: 0 h-index: 0机构: Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, State Key Lab Mol Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaXu, Binghe论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
- [7] CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (28) : 2836 - +Janjigian, Yelena Y.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USA Weill Cornell Med Coll, New York, NY USA Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USABendell, Johanna论文数: 0 引用数: 0 h-index: 0机构: Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USACalvo, Emiliano论文数: 0 引用数: 0 h-index: 0机构: Ctr Integral Oncol Clara Campal, START Madrid, Madrid, Spain Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USAKim, Joseph W.论文数: 0 引用数: 0 h-index: 0机构: Yale Canc Ctr, New Haven, CT USA Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USAAscierto, Paolo A.论文数: 0 引用数: 0 h-index: 0机构: Ist Nazl Tumori IRCCS Fdn Pascale, Naples, Italy Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USASharma, Padmanee论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USAOtt, Patrick A.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USAPeltola, Katriina论文数: 0 引用数: 0 h-index: 0机构: Docrates Canc Ctr, Helsinki, Finland Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USAJaeger, Dirk论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Heidelberg, Heidelberg, Germany Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USAEvans, Jeffry论文数: 0 引用数: 0 h-index: 0机构: Univ Glasgow, Glasgow, Lanark, Scotland Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USAde Braud, Filippo论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Milan, Italy Univ Milan, Milan, Italy Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USAChau, Ian论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, London, England Royal Marsden Hosp, Sutton, Surrey, England Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USAHarbison, Christopher T.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USADorange, Cecile论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USATschaika, Marina论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USALe, Dung T.论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA Mem Sloan Kettering Canc Ctr, 300 East 66th St,Room 1033, New York, NY 10065 USA
- [8] Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial[J]. BMC CANCER, 2020, 20 (01)Jiang, Haiping论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaZheng, Yulong论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaQian, Jiong论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaMao, Chenyu论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaXu, Xin论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaLi, Ning论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaXiao, Cheng论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaWang, Huan论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaTeng, Lisong论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Surg Oncol, Hangzhou, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaZhou, Hui论文数: 0 引用数: 0 h-index: 0机构: Innovent Biol Inc, Dept Med Sci & Strategy Oncol, Suzhou, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaWang, Shuyan论文数: 0 引用数: 0 h-index: 0机构: Innovent Biol Inc, Dept Med Sci & Strategy Oncol, Suzhou, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaZhu, Donglei论文数: 0 引用数: 0 h-index: 0机构: Innovent Biol Inc, Dept Med Sci & Strategy Oncol, Suzhou, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaPeng, Bo论文数: 0 引用数: 0 h-index: 0机构: Innovent Biol Inc, Dept Translat Med, Suzhou, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaShen, Lin论文数: 0 引用数: 0 h-index: 0机构: Beijing Canc Hosp, Dept Med Oncol, Beijing, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R ChinaXu, Nong论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol, 79,86 Qingchun Rd, Hangzhou 310003, Peoples R China
- [9] Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial[J]. LANCET, 2017, 390 (10111) : 2461 - 2471论文数: 引用数: h-index:机构:Boku, Narikazu论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Div Gastrointestinal Med Oncol, Tokyo 1040045, Japan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaSatoh, Taroh论文数: 0 引用数: 0 h-index: 0机构: Osaka Univ, Grad Sch Med, Frontier Sci Canc & Chemotherapy, Suita, Osaka, Japan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea论文数: 引用数: h-index:机构:Chao, Yee论文数: 0 引用数: 0 h-index: 0机构: Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaKato, Ken论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Div Gastrointestinal Med Oncol, Tokyo 1040045, Japan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaChung, Hyun Cheol论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ Hlth Syst, Yonsei Univ, Coll Med, Div Med Oncol,Med Oncol Yonsei Canc Ctr,Song Dang, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea论文数: 引用数: h-index:机构:Muro, Kei论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaKang, Won Ki论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaYeh, Kun-Huei论文数: 0 引用数: 0 h-index: 0机构: Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaYoshikawa, Takaki论文数: 0 引用数: 0 h-index: 0机构: Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaOh, Sang Cheul论文数: 0 引用数: 0 h-index: 0机构: Korea Univ, Coll Med, Dept Internal Med, Div Hematol & Oncol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaBai, Li-Yuan论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, China Med Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Taichung, Taiwan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaTamura, Takao论文数: 0 引用数: 0 h-index: 0机构: Kindai Univ, Fac Med, Dept Med Oncol, Osakasayama, Japan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaLee, Keun-Wook论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Coll Med, Bundang Hosp, Div Hematol & Oncol,Dept Internal Med, Seongnam, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaHamamoto, Yasuo论文数: 0 引用数: 0 h-index: 0机构: Keio Univ, Sch Med, Keio Canc Ctr, Tokyo, Japan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea论文数: 引用数: h-index:机构:Chin, Keisho论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaOh, Do-Youn论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaMinashi, Keiko论文数: 0 引用数: 0 h-index: 0机构: Chiba Canc Ctr, Dept Clin Trial Promot, Chiba, Japan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaCho, Jae Yong论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Med Oncol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaTsuda, Masahiro论文数: 0 引用数: 0 h-index: 0机构: Hyogo Canc Ctr, Dept Gastroenterol Oncol, Akashi, Hyogo, Japan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaChen, Li-Tzong论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Canc Res, Natl Hlth Res Inst, Tainan, Taiwan Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Tainan, Taiwan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
- [10] Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study[J]. EUROPEAN JOURNAL OF CANCER, 2020, 129 : 97 - 106Kawazoe, Akihito论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanYamaguchi, Kensei论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Dept Gastroenterol Chemotherapy, Canc Inst Hosp, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanYasui, Hisateru论文数: 0 引用数: 0 h-index: 0机构: Kobe City Med Ctr, Dept Med Oncol, Gen Hosp, Kobe, Hyogo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanNegoro, Yuji论文数: 0 引用数: 0 h-index: 0机构: Kochi Hlth Sci Ctr, Dept Gastroenterol, Kochi, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanAzuma, Mizutomo论文数: 0 引用数: 0 h-index: 0机构: Kitasato Univ, Dept Gastroenterol, Sch Med, Sagamihara, Kanagawa, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanAmagai, Kenji论文数: 0 引用数: 0 h-index: 0机构: Ibaraki Cent Hosp, Dept Gastroenterol, Ibaraki, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanHara, Hiroki论文数: 0 引用数: 0 h-index: 0机构: Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan论文数: 引用数: h-index:机构:Tsuda, Masahiro论文数: 0 引用数: 0 h-index: 0机构: Hyogo Canc Ctr, Dept Gastroenterol Oncol, Akashi, Hyogo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanHosaka, Hisashi论文数: 0 引用数: 0 h-index: 0机构: Gunma Prefectural Canc Ctr, Dept Gastroenterol, Gunma, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan论文数: 引用数: h-index:机构:Oshima, Takashi论文数: 0 引用数: 0 h-index: 0机构: Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanOmuro, Yasushi论文数: 0 引用数: 0 h-index: 0机构: Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Med Oncol, Komagome Hosp, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanMachida, Nozomu论文数: 0 引用数: 0 h-index: 0机构: Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanEsaki, Taito论文数: 0 引用数: 0 h-index: 0机构: Natl Hosp Org Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanYoshida, Kazuhiro论文数: 0 引用数: 0 h-index: 0机构: Gifu Univ, Dept Surg Oncol, Grad Sch Med, Gifu, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanNishina, Tomohiro论文数: 0 引用数: 0 h-index: 0机构: Natl Hosp Org Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan论文数: 引用数: h-index:机构:Han, Shi R.论文数: 0 引用数: 0 h-index: 0机构: MSD KK, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanShiratori, Shinichi论文数: 0 引用数: 0 h-index: 0机构: MSD KK, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, JapanShitara, Kohei论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan